Literature DB >> 16133299

[Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment].

C Maier1, C Schaub, A Willweber-Strumpf, M Zenz.   

Abstract

UNLABELLED: A total of 121 patients with at least a 3-year history of opioid use were evaluated by a standardized interview during a clinical visit or telephone call. Assessed items were the present and former drug medication, daily doses, withdrawals, contentment with the treatment, positive/negative treatment effects, average/maximum pain and others. STATISTICS: chi(2), ANCOVA and survival analysis. Of 121 patients (frequency of withdrawal 14.8% mainly due to lack of efficacy) with an average treatment time of 66 months (37-105 months; 80,264 days; 87% more than 5 years), 103 (85%) still took an opioid step II or III according to the WHO analgesic ladder. Patients further treated in the pain clinic stopped significantly less frequently than patients treated by GPs or other non-specialised physicians (5 versus 23%). Patients with long-term opioid intake revealed significantly lower pain intensity and higher contentment with the pain management and achieved improvement (global, quality of life and physical state). Changes of opioid dosages during the 5 years were inconsistent (no change 33%, decrease 16%, slight increase 27%, high increase 19%). However, the number of patients with high dose increased from 6 to 23 due to significant loss of efficacy (proved in the morphine subgroup, p<0.05). The survey demonstrates a very low frequency of withdrawal in patients with long-term opioid medication after initial response without evidence for tolerance development, especially if their treatment is controlled in a pain centre.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133299     DOI: 10.1007/s00482-005-0432-9

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  19 in total

1.  Recommendations for using opioids in chronic non-cancer pain.

Authors:  Eija Kalso; Laurie Allan; Paul L I Dellemijn; Clara C Faura; Wilfried K Ilias; Troels S Jensen; Serge Perrot; Leon H Plaghki; Michael Zenz
Journal:  Eur J Pain       Date:  2003       Impact factor: 3.931

Review 2.  Opioid therapy for chronic pain.

Authors:  Jane C Ballantyne; Jianren Mao
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

Review 3.  [Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain].

Authors:  J Jage; A Willweber-Strumpf; C Maier
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 4.  Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.

Authors:  Elon Eisenberg; Ewan D McNicol; Daniel B Carr
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

5.  Long-term oral opioid therapy in patients with chronic nonmalignant pain.

Authors:  M Zenz; M Strumpf; M Tryba
Journal:  J Pain Symptom Manage       Date:  1992-02       Impact factor: 3.612

6.  The effect of opioids on phantom limb pain and cortical reorganization.

Authors:  E Huse; W Larbig; H Flor; N Birbaumer
Journal:  Pain       Date:  2001-02-01       Impact factor: 6.961

7.  Long-term opioid analgesic therapy for severe refractory lumbar spine pain.

Authors:  J Schofferman
Journal:  Clin J Pain       Date:  1999-06       Impact factor: 3.442

8.  Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain.

Authors:  P L Dellemijn; J A Vanneste
Journal:  Lancet       Date:  1997-03-15       Impact factor: 79.321

9.  [Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?].

Authors:  S Schulzeck; M Gleim; C Maier
Journal:  Anaesthesist       Date:  1993-08       Impact factor: 1.041

Review 10.  Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin.

Authors:  J Schofferman
Journal:  J Pain Symptom Manage       Date:  1993-07       Impact factor: 3.612

View more
  8 in total

1.  [Physicians do not treat averages--but therapy responders!].

Authors:  C Maier; R Baron
Journal:  Schmerz       Date:  2012-02       Impact factor: 1.107

2.  An exploration of opioid medication management for non-malignant pain in primary care.

Authors:  Jia Song; Jens Foell
Journal:  Br J Pain       Date:  2015-08

3.  [Addition is also a disease].

Authors:  C Maier
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

4.  Long-term opioid use in non-cancer pain.

Authors:  Winfried Häuser; Fritjof Bock; Peter Engeser; Thomas Tölle; Anne Willweber-Strumpfe; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

Review 5.  [Epidemiology of chronic non-malignant pain in Germany].

Authors:  R Wolff; C Clar; C Lerch; J Kleijnen
Journal:  Schmerz       Date:  2011-02       Impact factor: 1.107

Review 6.  [Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].

Authors:  W Häuser; K Bernardy; C Maier
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

7.  Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients.

Authors:  Lucy Chen; Trang Vo; Lindsey Seefeld; Charlene Malarick; Mary Houghton; Shihab Ahmed; Yi Zhang; Abigail Cohen; Cynthia Retamozo; Kristen St Hilaire; Vivian Zhang; Jianren Mao
Journal:  J Pain       Date:  2013-02-26       Impact factor: 5.820

8.  The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents.

Authors:  Winfried Häuser; Stephan Schug; Andrea D Furlan
Journal:  Pain Rep       Date:  2017-05-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.